National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government`s Profile
This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.
How does the overall patent portfolio of National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government look like?
Total Applications: | 35070 |
Granted Patents: | 21775 |
Grant Index | 67.4 % |
Abandoned/Rejected Applications: | 10534 (32.6%) |
In-Process Applications: | 2756 |
Average Grant Time: | 3.39 Years |
Average Office Actions: | 2.07 |
Which Technology Area National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government is filing most patents in? (Last 10 years)
Art Unit | Definition | Total Applications |
1644 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 1204 |
1648 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 1151 |
1634 | Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry | 1144 |
1633 | Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry | 1120 |
1632 | Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry | 1068 |
How many patents are National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government filing every year?
Year | Total Applications |
2022 | 0* |
2021 | 4* |
2020 | 195 |
2019 | 243 |
2018 | 844 |
*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published
Recently filed patent applications of National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government in USPTO?
Abstract:
Publication date: 2022-01-13
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Havel J William
Publication number: US20210299239A1
Abstract:
Further provided is an anti-cancer agent comprising a CpG oligonucleotide and is characterized in that the CpG oligonucleotide is administered together with an STING agonist. Still further provided is a composition which contains a CpG oligonucleotide and can be used for reducing or eliminating the IgE-inducing activity of an STING agonist.
Publication date: 2021-09-30
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Etsushi Kuroda
Publication number: –
Abstract:
None
Publication date: –
Applicant: National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government
Inventors: Guosheng Wu
How are National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government’s applications performing in USPTO?
Application Number | Title | Status | Art Unit | Examiner |
17385230 | Vascular Anchoring Introducer Sheath | – | OPAP | Central, Docket |
17344627 | Novel Th1-Inducing Adjuvant Comprising Combination Of Different Nucleic Acid Adjuvants, And Use Of Same | Docketed New Case – Ready for Examination | OPAP | Central, Docket |
17309270 | Spiro Compound And Medical Uses Thereof | Docketed New Case – Ready for Examination | OPAP | Central, Docket |
17286359 | Method For Determining Glomerular Filtration Ability | Docketed New Case – Ready for Examination | OPAP | Central, Docket |